Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial.
Saved in:
| Title: | Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial. |
|---|---|
| Authors: | Puskarich MA; Department of Emergency Medicine, University of Minnesota, Minneapolis.; Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota., Ingraham NE; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis., Merck LH; Department of Emergency Medicine, University of Florida College of Medicine, Gainesville., Driver BE; Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota., Wacker DA; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis., Black LP; Department of Emergency Medicine, University of Florida College of Medicine, Jacksonville., Jones AE; Department of Emergency Medicine, University of Mississippi Medical Center, Jackson., Fletcher CV; Center for Drug Discovery, University of Nebraska Medical Center, Omaha., South AM; Section of Nephrology, Department of Pediatrics, Wake Forest School of Medicine and Brenner Children's Hospital, Winston Salem, North Carolina.; Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston Salem, North Carolina.; Department of Surgery-Hypertension and Vascular Research, Wake Forest School of Medicine, Winston Salem, North Carolina., Murray TA; Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis., Lewandowski C; Department of Emergency Medicine, Henry Ford Hospital, Wayne State University, Detroit, Michigan., Farhat J; Department of Surgery, North Memorial Medical Center, Minneapolis, Minnesota., Benoit JL; Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio., Biros MH; Department of Emergency Medicine, University of Minnesota, Minneapolis., Cherabuddi K; Department of Emergency Medicine, University of Florida College of Medicine, Gainesville., Chipman JG; Department of Surgery, University of Minnesota, Minneapolis., Schacker TW; Division of Infectious Disease, Department of Medicine, University of Minnesota, Minneapolis., Guirgis FW; Department of Emergency Medicine, University of Florida College of Medicine, Jacksonville., Voelker HT; Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis., Koopmeiners JS; Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis., Tignanelli CJ; Department of Surgery, University of Minnesota, Minneapolis. |
| Corporate Authors: | Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators |
| Source: | JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e222735. Date of Electronic Publication: 2022 Mar 01. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2022.2735 |
